Skip to content

    Indrayani Biotech share price & financials

    Overview

    Price

    Market Cap

    ₹83 Cr

    Sector

    Rank

    Key metrics

    Company lens

    Revenue growth
    +5.8%
    FY26 vs FY25
    Operating margin
    7.0%+0.6 pp YoY
    TTM · Q4 FY26
    ROCE
    4.5%
    TTM · Q4 FY26 on FY26 capital
    ROE
    2.9%
    TTM · Q4 FY26 on FY26 equity
    Debt / equity
    1.92×
    FY26
    P/E
    38.2×
    TTM · Q4 FY26

    Performance34.2% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly

    Balance Sheet

    Balance Sheet

    ₹ Cr · Annual
    Line itemFY12FY20FY21FY22FY23FY24FY25FY26TTM
    LiabilitiesEquity Capital4434343446464646
    Reserves027-15-101222273027
    Borrowings014161979113137146128
    Other Liabilities97583154585252
    Total Liabilities12514051156234268274253
    AssetsFixed Assets61715175762586260
    CWIP01414131420262327
    Investments000000000
    Other Assets721112285151184189166
    Total Assets12514051156234268274253

    Cash Flow

    Cash Flow

    ₹ Cr · Annual
    Line itemFY11FY12FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating1260416-30-732
    Cash from Investing-30-4-1-1-47-1625-13
    Cash from Financing2-1-10-33344-18-15
    SummaryCapital Expenditure
    Free Cash Flow-22203-25-47-823
    FCF Margin-28.3%-6.1%

    Ratios

    Ratios

    Annual
    RatioFY12FY20FY21FY22FY23FY24FY25FY26YoY3-yr
    Growth-21.7%5.8%+27.5 ppImproving
    -156.1%
    Profitability14.1%6.4%7.0%+0.6 ppWorsening
    6.6%-4.7%1.6%+6.3 ppWorsening
    Returns16.0%-8.4%−24.4 ppWorsening
    11.5%2.2%−9.3 ppWorsening
    4.7%-2.3%−6.9 ppWorsening
    Leverage0.00×0.45×0.84×0.79×1.72×1.66×1.88×+0.21×Worsening
    2.11×0.45×1.03×+0.59×Worsening
    Efficiency0.71×0.49×−0.22×Worsening
    -275.2%

    Margins, returns, leverage and efficiency are computed from the filed statements (year-end balances). 3-yr compares the latest year with three years earlier; small moves read as stable.

    Shareholding

    Shareholding

    Who owns Indrayani Biotech Ltd.

    As of Jun 2026 · 25,811 shareholders

    Since Jun 2025, promoters trimmed −0.36 pp while the public added +0.32 pp.

    Ownership split

    Promoters
    32.92%
    −0.34 pp QoQ−0.36 pp since Jun '25
    DIIs
    3.13%
    0.00 pp QoQ+0.02 pp since Jun '25
    Public
    63.94%
    +0.32 pp QoQ+0.32 pp since Jun '25

    Ownership drift

    Last 12 disclosures

    • Promoters
    • DIIs
    • Public

    Percentages are as disclosed in the company's shareholding pattern filings. Named holders appear only above SEBI's 1% disclosure threshold, so a holder dropping off the list may have trimmed to just under 1% — or been re-filed under a new name — rather than exited.

    Valuation

    Cyclical, with too little history

    This looks cyclical, and we don't have enough quarters to establish a through-cycle earnings base. Valuing it off the current point in the cycle would be misleading.

    INDRANIB · CYCLICAL_UNMODELABLE

    Learn to analyse Indrayani Biotech Ltd.

    Guides on how to read this kind of business and the numbers that matter.